SCHEDULE 13G/A
SCHEDULE 13G/ASchedule 13G ownership disclosure
ROIVANT SCIENCES LTD SHS
Common Shares, $0.0000000341740141 par value per share · CUSIP: G76279101
Event date: 2025-09-30
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- VIKING GLOBAL INVESTORS LP
Shares: 23,594,831 · Class: 3.4%
- VIKING GLOBAL PERFORMANCE LLC
Shares: 12,504,401 · Class: 1.8%
- Viking Global Equities II LP
Shares: 250,088 · Class: 0.04%
- Viking Global Equities Master Ltd.
Shares: 12,254,313 · Class: 1.8%
- Viking Long Fund GP LLC
Shares: 4,851,726 · Class: 0.7%
- Viking Long Fund Master Ltd.
Shares: 4,851,726 · Class: 0.7%
- Viking Global Opportunities Parent GP LLC
Shares: 6,238,704 · Class: 0.9%
- Viking Global Opportunities GP LLC
Shares: 6,238,704 · Class: 0.9%
- Viking Global Opportunities Portfolio GP LLC
Shares: 6,238,704 · Class: 0.9%
- Viking Global Opportunities Illiquid Investments Sub-Master LP
Shares: 6,238,704 · Class: 0.9%
- HALVORSEN OLE ANDREAS
Shares: 23,594,831 · Class: 3.4%
- Ott David C.
Shares: 23,594,831 · Class: 3.4%
- Shabet Rose Sharon
Shares: 23,594,831 · Class: 3.4%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000905148-25-004064
- Form type
- SCHEDULE 13G/A
- Filer
- Roivant Sciences Ltd.
- CIK
- CIK 1635088
- Filed
- Nov 14, 2025
- Reporting period
- Sep 30, 2025
- Description
- Schedule 13G beneficial ownership